Hepatitis E and pregnancy: Understanding the pathogenesis

Liver International

Volumn 28, Issue 9, 2008, Pages 1190-1199

  Navaneethan, Udayakumar ^a   Al Mohajer, Mayar ^a   Shata, Mohamed T ^b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Fulminant liver failure; Hepatitis E; Hormonal; Immunology; Pregnancy

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; CHORIONIC GONADOTROPIN; ESTROGEN; HEPATITIS E ANTIBODY; HLA ANTIGEN; HLA G ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 4; PHYTOHEMAGGLUTININ; PROGESTERONE; SYNAPTOTAGMIN I;

ANTIBODY PRODUCTION; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL FEATURE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; EPIDEMIC; GENETIC SUSCEPTIBILITY; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HORMONE ACTION; HOST SUSCEPTIBILITY; HUMAN; IMMUNOREGULATION; INCIDENCE; INDUCED ABORTION; INFECTION RISK; LIVER FAILURE; MORBIDITY; MORTALITY; PREGNANCY; PREVALENCE; REVIEW; T LYMPHOCYTE; TH2 CELL; TROPHOBLAST; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ANIMALS; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HORMONES; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 51649119877     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01840.x     Document Type: Review

References (86)

1. Purcell R, Emerson S. Viral hepatitis. In: Mandell GL, Douglas RG, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennet's Principles and Practice of Infectious Diseases, 6th edn. New York: Elsevier/Churchill Livingstone, 2005; 2204-17.
2. Vishwanathan R. Infectious hepatitis in Delhi (1955-56): A critical study. Epidemiology. Indian J Med Res 1957; 45(Suppl. 1): 1-29.
3. Wong DC, Purcell RH, Sreenivasan MA, Prasad SR, Pavri KM. Epidemic and endemic hepatitis in India: Evidence for non-A, non-B hepatitis virus etiology. Lancet 1980; 2: 876-9.
4. Khuroo MS. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post transfusion non-A, non-B type. Am J Med 1980; 68: 818-24.
5. Dawson GJ, Chau KH, Cabol CM, Yarbough PO, Reyes GR, Mushahwar IK. Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J Virol Meth 1992; 38: 175-86.
6. Renou C, Moreau X, Pariente A, et al. A national survey of acute hepatitis E in France. Aliment Pharmacol Ther 2008; 27: 1086-93.
7. Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008; 358: 811-7.
8. Beniwal M, Kumar A, Kar P, Jilani N, Sharma JB. Prevalence and severity of acute viral hepatitis and fulminant hepatitis during pregnancy: A prospective study from north India. Indian J Med Microbiol 2003; 21: 184-5.
9. Medhat A, el-Sharkawy MM, Shaaban MM, Makhlouf MM, Ghaneima SE. Acute viral hepatitis in pregnancy. Int J Gynaecol Obstet 1993; 40: 25-31.
10. Tsega E, Krawczynski K, Hansson BG, Nordenfelt E. Hepatitis E virus infection in pregnancy in Ethiopia. Ethiop Med J 1993; 31: 173-81.
11. Strand RT, Franque-Ranque M, Bergstrom S, Weiland O. Infectious etiology of jaundice among pregnant women in Angola. Scand J Infect Dis 2003; 35: 401-3.
12. Kumar A, Beniwal M, Kar P, Sharma JB, Murthy NS. Hepatitis E in pregnancy. Int J Gynaecol Obstet 2004; 85: 240-4.
13. Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 2007; 147: 28-33.
14. Singh S, Mohanty A, Joshi YK, Deka D, Mohanty S, Panda SK. Mother to child transmission of hepatitis E virus infection. Indian J Pediatr 2003; 70: 37-9.
15. Jaiswal SPB, Jain AK, Naik G, Soni N, Chitnis DS. Viral hepatitis during pregnancy. Int J Gynaec Obstet 2001; 72: 103-8.
16. Khuroo MS, Kamili S. Etiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat 2003; 10: 61-9.
17. Schlauder GG, Mushahwar IK. Genetic heterogeneity of hepatitis E virus. J Med Virol 2001; 65: 282-92.
18. Fields BN, Knipe DM. Fields Virology, Vol. 2. 2nd edn. New York: Raven Press, 1990, xix, p. 2336.
19. Mizuo H, Yazaki Y, Sugawara K, et al. Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan. J Med Virol 2005; 76: 341-9.
20. Emerson SU, Purcell RH. Hepatitis E virus. Rev Med Virol 2003; 13: 145-54.
21. Naik SR, Aggrawal R, Salunke PN, Mehrotra NN. A large waterborne hepatitis E epidemic in Kanpur, India. Bull WHO 1992; 70: 597-604.
22. Robson SC, Adams S, Brink N, Woodruff B, Bradley D. Hospital outbreak of hepatitis E. Lancet 1992; 339: 1424-5.
23. Khuroo MS, Kamili S, Jameel S. Vertical transmission of hepatitis E virus. Lancet 1995; 345: 1025-6.
24. Psichogiou M, Tzala E, Boletis J, et al. Hepatitis E virus infection in individuals at high risk of transmission of non-A, non-B hepatitis and sexually transmitted diseases. Scand J Infect Dis 1996; 28: 443-5.
25. Brazilai A, Schulman S, Karetnyi YV, et al. Hepatitis E virus infection in hemophiliacs. J Med Virol 1995; 46: 153-6.
26. Tsega E, Hansson BG, Krawczynski K, Nordefelt E. Acute Sporadic viral hepatitis in Ethiopia: Causes, risk factors, and effects on pregnancy. Clin Infect Dis 1992; 14: 961-5.
27. Kane MA, Bradely DW, Shrestha SM, et al. Epidemic non-A, non-B hepatitis in Nepal: Recovery of a possible etiologic agent and transmission studies in marmosets. JAMA 1984; 252: 3140-5.
28. Centers for Disease Control and Prevention. Hepatitis E among US travelers, 1989-1992. Morb Mortal Wkly Rep 1993; 42: 1-4.
29. De Cock KM, Bradley DW, Sandford NL, Govindarajan S, Maynard JE, Redekar AG. Epidemic non-A, non-B hepatitis in patients from Pakistan. Ann Intern Med 1987; 106: 227-30.
30. Stoszek SK, Abdel-Hamid M, Saleh DA, et al. High prevalence of hepatitis E antibodies in pregnant Egyptian women. Trans R Soc Trop Med Hyg 2006; 100: 95-101. Epub 28 October 2005.
31. Stoszek SK, Engle RE, Abdel-Hamid M, et al. Hepatitis E antibody seroconversion without disease in highly endemic rural Egyptian communities. Trans R Soc Trop Med Hyg 2006; 100: 89-94. Epub 28 October 2005.
32. Kumar RM, Uduman S, Rana S, Kochiyil JK, Usmani A, Thomas L. Sero-prevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynecol Reprod Biol 2001; 100: 9-15.
33. Aggarwal R. Hepatitis E and pregnancy. Indian J Gastroenterol 2007; 26: 3-5.
34. Hunt JS. Cytokine networks in the uteroplacental unit: Macrophages as pivotal regulatory cells. J Reprod Immunol 1989; 16: 1-17.
35. Marzi M, Vigano A, Trabattoni D, et al. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996; 106: 127-33.
36. Sakaguchi S. Regulatory T cells: Key controllers of immunologic self-tolerance. Cell 2000; 101: 455.
37. R Mellor AL, Sivakumar J, Chandler P, et al. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2001; 2: 64.
38. Orsi NM, Gopichandran N, Ekbote UV, Walker JJ. Murine serum cytokines throughout the estrous cycle, pregnancy and post partum period. Anim Reprod Sci 2006; 96: 54-65.
39. Dudley DJ, Chen C, Mitchell MD, Daynes RA, Araneo BA. Adaptive immune responses during murine pregnancy: Pregnancy-induced regulation of lymphokine production by activated T lymphocytes. Am J Obstet Gynecol 1993; 168: 1155-63.
40. Cahill KM. Hepatitis in pregnancy. Surg Gynaecol Obstet 1962; 114: 545-52.
41. Purtilo DT, Hallgren HM, Yunis EJ. Depressed maternal response to phytohaemagglutinin in human pregnancy. Lancet 1972; 1: 769-71.
42. Lewis J Jr, Whang J, Nagel B, Oppenheim JJ, Perry S. Lymphocyte transformation in mixed leukocyte cultures in women with normal pregnancy or tumor of placental origin. A preliminary report. Am J Obstet Gynecol 1966; 96: 287-90.
43. Meeusen EN, Bischof RJ, Lee CS. Comparative T-cell responses during pregnancy in large animals and humans. Am J Reprod Immunol 2001; 46: 169-79.
44. Riley EM, Schneider G, Sambou I, Greenwood BM. Suppression of cell-mediated immune responses to malaria antigens in pregnant Gambian women. Am J Trop Med Hyg 1989; 40: 141-4.
45. Priddy KD. Immunologic adaptations during pregnancy. J Obstet Gynecol Neonatal Nurs 1997; 26: 388.
46. Biggar RJ, Pahwa S, Minokoff H, et al. Immunosuppression in pregnant women infected with human immunodeficiency virus. Am J Obstet Gynecol 1989; 161: 1239-44.
47. Coulam CB, Silverfield JC, Kazmar RE, Fathman CG. T-Lymphocyte subsets during pregnancy and the menstrual cycle. Am J Reprod Immunol 1983; 4: 88-90.
48. Glassman AB, Bennett CE, Christopher JB, Self S. Immunity during pregnancy: Lymphocyte subpopulations and mitogen responsiveness. Ann Clin Lab Sci 1985; 15: 357-62.
49. Sridama V, Pacini F, Yang SL, Moawad A, Reilly M, Degroot LJ. Decreased levels of helper T cells: A possible cause of immunodeficiency in pregnancy. N Engl J Med 1982; 307: 352-6.
50. Tallon DF, Corcoran DJ, O'Dwyer GM, Greally JF. Circulating lymphocyte subpopulation in pregnancy: A longitudinal study. J Immunol 1984; 132: 1784-7.
51. Barnett MA, Learmonth RP, Pihl E, Wood EC. T-helper lymphocyte depression in early human pregnancy. J Reprod Immunol 1983; 5: 55-7.
52. Malinowshki A, Szpakowski M, Tchorzewski H, Zeman K, Pawlowicz P, Wozniac P. T-lymphocyte subpopulations and lymphocyte proliferative activity in normal and pre-eclamptic pregnancies. Eur J Obstet Gynecol Reprod Biol 1994; 53: 27-31.
53. Degenne D, Canepa S, Lecomte C, Renoux M, Bardos P. Serial study of T-lymphocyte subsets in women during very early pregnancy. Clin Immun Immunopathol 1988; 48: 187-91.
54. Canapa S, Horowitz R, Degenne D, Magnin G, Valat C, Bardos P. Correlation of plasma hormone levels and peripheral circulating lymphocyte subpopulation during human pregnancy. Immunol Lett 1984; 8: 159-63.
55. + T lymphocytes during normal human pregnancy. J Reprod Immunol 1989; 15: 103-11.
56. Arankalle VA, Chadha MS, Dama BM, Tsarvey SA, Purcell RM, Banerjee K. Role of immune serum globulins in pregnant women during an epidemic of hepatitis E. J Viral Hepat 1998; 5: 199-204.
57. Ponta H, Kennedy N, Scroch P, Hynes NE, Groner B. Hormonal response region in the mouse mammary tumor virus long terminal repeat can be dissociated from the proviral promoter and has enhancer properties. Proc Natl Acad Sci USA 1985; 82: 1020-4.
58. Han T. Human chorionic gonadotropin. Its inhibitory effect on cell-mediated immunity in vivo and in vitro. Immunology 1975; 29: 509-15.
59. Boll G, Reimann J. Estrogen treatment depletes extrathymic T cells from intestinal lymphoid tissues. Scand J Immunol 1996; 43: 345-50.
60. Rijhisinghami AG, Thompson K, Bhatia SK, Waldscmidt TJ. Estrogen blocks early T cell development in the thymus. Am J Reprod Immunol 1996; 36: 267-77.
61. Tibbets TA, de Mayo F, Rich S, Conneely OM, Omalley BW. Progesterone receptors in the thymus are required for thymic involution during pregnancy and for normal fertility. Proc Natl Acad Sci USA 1999; 96: 12021-6.
62. Medina KL, Smithson G, Kincade PW. Suppression of B lymphopoiesis during normal pregnancy. J Exp Med 1993; 178: 1507.
63. Styrt B, Sugarman B. Estrogens and infection. Rev Infect Dis 1991; 13: 1139-50.
64. Hussaini SH, Skidmore SJ, Richardson P, Sherratt LM, Cooper BT, O'Grady JG. Severe hepatitis E infection during pregnancy. J Viral Hepat 1997; 4: 51-4.
65. Barbara H, McGovern BH, Dietelberg, JS, et al. Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients. Clin Infect Dis 2006; 43: 365-72.
66. Mellor AM, Munn DH. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol Today 1999; 20: 469-73.
67. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Ann Rev Cell Biol 1994; 10: 405-55.
68. Prusty BK, Hedau S, Singh A, Kar P, Das BC. Selective suppression of NF-kBp65 in hepatitis virus-infected pregnant women manifesting severe liver damage and high mortality. Mol Med 2007; 13: 518-26.
69. Boya P, Larrea E, Sola I, et al. Nuclear factor-kappa B in the liver of patients with chronic hepatitis C: Decreased RelA expression is associated with enhanced fibrosis progression. Hepatology 2001; 34: 1041-8.
70. McCracken SA, Drury CL, Lee HS, Morris JM. Pregnancy is associated with suppression of the nuclear factor kappaB/IkappaB activation pathway in peripheral blood mononuclear cells. J Reprod Immunol 2003; 58: 27-47.
71. Jilani N, Das BC, Husain SA, et al. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J Gastroenterol Hepatol 2007; 22: 676-82.
72. Pal R, Aggarwal R, Naik SR, Das V, Das S, Naik S. Immunological alterations in pregnant women with acute hepatitis E. J Gastroenterol Hepatol 2005; 20: 1094-101.
73. Fried M, Duffy PE. Adherence of plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 1996; 272: 1502-4.
74. Morell V. Zeroing in on how hormones affect the immune system. Science 1995; 269: 773-5.
75. Singh N, Shukla MM, Sharma VP. Epidemiology of malaria in pregnancy. Bull WHO 1999; 77: 567.
76. Matthiesen L, Berg G, Ernerudh J, Hakansson L. Lymphocyte subsets and mitogen stimulation of blood lymphocytes in normal pregnancy. Am J Reprod Immunol 1996; 35: 70-9.
77. Rasheeda CA, Navaneethan U, Jayanthi V. liver Disease in pregnancy and its influence on maternal and fetal mortality - a prospective study from Chennai, Southern India. Eur J Gastroenterol Hepatol 2008; 20: 362-4.
78. Arankalle VA, Paranjape S, Emerson SU, Purcell RH, Walimbe AM. Phylogenetic analysis of hepatitis E virus isolates from India (1976-1993). J Gen Virol 1999; 80: 1691-700.
79. Khuroo MS, Kamili S, Yattoo GN. Severe fetal hepatitis E virus infection is the possible of increased severity of hepatitis E virus infection in the mother: Another example of mirror syndrome. Indian J Gastroenteral 2004; 23(Suppl. 1): A1.
80. Hohler T, Reuss E, Evers N, et al. Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis. A virus: A vaccination study in twins. Lancet 2002; 360: 991-5.
81. Thio CL, Carrington M, Marti D, et al. Class II HLA alleles and hepatitis B virus persistence in African Americans. J Infect Dis 1999; 179: 1004-6.
82. Bernuau JR, Durand F. Herbal medicines in acute viral hepatitis: A ticket for more trouble. Eur J Gastroenterol Hepatol 2008; 20: 161-3.
83. Udayakumar N, Subramaniam K, Umashankar L, Verghese J, Jayanthi V. Predictors of mortality in hepatic encephalopathy in acute and chronic liver disease: A preliminary observation. J Clin Gastroenterol 2007; 41: 922-6.
84. Mjahed K, Charra B, Hamoudi D, Noun M, Barrou L. Acute fatty liver of pregnancy. Arch Gynecol Obstet 2006; 274: 349-53.
85. Banait VS, Sandur V, Parikh F, et al. Outcome of acute liver failure due to acute hepatitis E in pregnant women. Indian J Gastroenterol 2007; 26: 6-10.
86. Arankalle VA, Chadha MS, Dama BM, Tsarev SA, Purcell RH, Banerjee K. Role of immune serum globulins in pregnant women during an epidemic of hepatitis E. J Viral Hepat 1998; 5: 199-204.